
Amitriptyline
Amitriptyline is an effective antidepressant: in a large network meta-analysis it had the highest response odds versus placebo of 21 antidepressants, but also among the highest dropout rates because of side effects. For supplement users, the key points are to avoid alcohol and St. John's wort, and to check any serotonin-raising product with a pharmacist first.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with depression whose prescriber has chosen amitriptyline, often when sedation is acceptable or helpful. The label gives lower doses for adolescents but says safety and effectiveness in children and teens have not been established
Common dosing range
Set by your prescriber, starting low. The label's usual outpatient start is 75 mg a day in divided doses or 50 to 100 mg at bedtime, up to 150 mg a day; maintenance is usually 50 to 100 mg a day. Older adults and adolescents usually take less
When to expect effects
Sedation can appear within days; the label says the full antidepressant effect may take as long as 30 days
Watch out for
Boxed warning for suicidal thoughts in people under 25. The label rules out combining it with MAOI antidepressants (or within 14 days of stopping one), linezolid or intravenous methylene blue. Serotonin syndrome is possible with other serotonin-raising drugs and supplements. It adds to alcohol's effects and is dangerous in overdose
What is it
Amitriptyline is a prescription tricyclic antidepressant taken as a tablet, one of the oldest antidepressants still in wide use. It is sold mainly as generic amitriptyline hydrochloride, and also under the brand name Elavil. The FDA label approves it for the relief of symptoms of depression and says it is not recommended for children under 12. Doctors also often prescribe it in low doses off-label, for example for nerve pain, a use the label does not cover. It has a boxed warning about suicidal thoughts in children, teens and young adults.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
depression in adults Good Evidence | Moderate; response odds about twice placebo (OR 2.13) | Adults with major depression who can tolerate sedating and anticholinergic side effects | Weeks; the label says the full effect may take up to 30 days |
nerve (neuropathic) pain, an off-label use Mixed Evidence | Uncertain; helps a minority of people | Adults with nerve pain whose prescriber suggests a trial | Not established by these trials |
depression in adults
- Effect
- Moderate; response odds about twice placebo (OR 2.13)
- Best fit
- Adults with major depression who can tolerate sedating and anticholinergic side effects
- Time
- Weeks; the label says the full effect may take up to 30 days
nerve (neuropathic) pain, an off-label use
- Effect
- Uncertain; helps a minority of people
- Best fit
- Adults with nerve pain whose prescriber suggests a trial
- Time
- Not established by these trials
Evidence for 2 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
depression in adults
Disease adjunctA 2018 network meta-analysis pooled 522 double-blind trials (116,477 adults) of 21 antidepressants for acute major depression. Every drug beat placebo, and amitriptyline had the highest odds of response (OR 2.13). In head-to-head trials it was among the more effective drugs, but also among those with the highest dropout rates, reflecting its side effects. The authors rated the certainty of evidence moderate to very low, and the trials covered acute (short-term) treatment only.
Bottom line: Amitriptyline is among the most effective antidepressants but harder to tolerate than newer ones.
nerve (neuropathic) pain, an off-label use
Disease adjunctNerve pain is not an FDA-labeled use, but amitriptyline is widely prescribed for it. A 2015 Cochrane review of 17 studies (1,342 participants) across seven nerve pain conditions found no good-quality evidence. In only 2 of 7 studies with useful data was amitriptyline clearly better than placebo (very low quality evidence). Side effects were more common: 55% versus 36% on placebo had at least one. The reviewers concluded that only a minority of people get satisfactory relief, while noting decades of clinical use and no good evidence that it does not work.
Bottom line: Amitriptyline helps some people with nerve pain, but the trial evidence is weak.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose; avoid alcohol and check every supplement with your pharmacist.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: antidepressants increased suicidal thoughts and behavior in children, teens and young adults up to 24 in short-term studies; people of all ages need close watching for worsening or unusual behavior, especially in the first months and after dose changes.
Serotonin syndrome, potentially life-threatening, especially with other serotonin-raising drugs and supplements (triptans, SSRIs, tramadol, lithium, tryptophan, St. John's wort) or MAOIs.
Heart rhythm problems, fast heartbeat and slowed conduction, particularly at high doses; heart attack and stroke have been reported with this drug class. Overdose can be fatal.
Angle-closure glaucoma attacks in people with narrow eye angles, and urinary retention, from its atropine-like effects.
Low blood sodium (hyponatremia), more likely in older adults, people on diuretics and people who are dehydrated.
Switch to mania or hypomania in people with bipolar disorder, worse psychosis, and seizures in people with a seizure history.
Who should avoid it
- People taking an MAOI antidepressant or who stopped one within 14 days, and people being given linezolid or intravenous methylene blue
- People taking cisapride, because of the risk of QT prolongation and arrhythmia
- People in the acute recovery phase after a heart attack, and anyone with a past allergy to amitriptyline
- Children under 12 (not recommended by the label)
Pregnancy & breastfeeding
Pregnancy: amitriptyline crosses the placenta. There are no adequate, well-controlled studies in pregnant women, and a few reports of problems in exposed infants (nervous system effects, limb deformities or developmental delay) without a proven cause. The label says to use it in pregnancy only if the benefit justifies the risk, so talk to your prescriber before or as soon as you plan or confirm a pregnancy. Breastfeeding: amitriptyline passes into breast milk; in one report, milk levels were similar to the mother's blood levels but none was detected in the infant's blood. The label asks that the decision to breastfeed or continue the drug be made with your prescriber.
Interactions
The label lists MAOIs as a contraindication: high fever, severe convulsions and deaths have occurred with the combination. At least 14 days must pass after stopping an MAOI before amitriptyline is started.
Amitriptyline is sedating, and the label says it may enhance the response to alcohol and other sedatives, which adds to drowsiness and poor coordination. In people who drink heavily, this also raises the danger of an overdose. Avoid alcohol unless your prescriber says otherwise, and do not drive until you know how the combination affects you.
In 12 patients on amitriptyline 75 mg twice daily, adding St. John's wort extract (900 mg a day) for about 2 weeks cut amitriptyline exposure by 22% and its active metabolite nortriptyline by 41%, which could weaken its effect. The label also lists St. John's wort among products that raise the risk of serotonin syndrome with amitriptyline. Do not combine them without your prescriber, and if you already take both, ask before stopping either.
These drugs block the enzyme that clears amitriptyline, and the label warns that a person stable on a tricyclic can become abruptly toxic when one is added; exposure can rise up to 8-fold in people who clear it slowly. After stopping fluoxetine, at least 5 weeks may be needed before starting a tricyclic. Your prescriber may lower doses or check levels.
The label warns that combining amitriptyline with these raises the risk of serotonin syndrome, particularly when starting or raising a dose. Make sure every prescriber knows you take amitriptyline.
Tryptophan is the amino acid the body turns into serotonin, and the amitriptyline label lists it among serotonergic products that raise the risk of serotonin syndrome, particularly when treatment starts or the dose goes up. No case with this exact pair has been published. Do not add a tryptophan supplement unless your prescriber advises it, and seek urgent care for agitation, tremor, sweating, fever or a racing heart.
5-HTP is the body's direct building block for serotonin, so it adds to amitriptyline's serotonin effect. The label lists tryptophan, the amino acid the body turns into 5-HTP, among products that raise the risk of serotonin syndrome; it does not name 5-HTP itself, and no case with this pair has been published. Do not combine them unless your prescriber directs it, and seek urgent care for agitation, tremor, sweating, fever or a racing heart.
Saffron extract has been tested as an antidepressant in small trials, and its effects may involve serotonin, so in theory it could add to amitriptyline's serotonin effect. The review cited here looked at saffron's own antidepressant effect, not at saffron taken with amitriptyline, so whether the two interact is not known. Tell your prescriber if you use a saffron supplement, and watch for agitation, sweating, tremor or a racing heart.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (4)
+ alcohol
highAmitriptyline is a sedating tricyclic antidepressant with strong antihistaminic and anticholinergic effects. Combining it with alcohol, also a central nervous system depressant, produces additive drowsiness, impaired coordination and reaction time, and a greater risk of falls and accidents. The FDA label warns explicitly that amitriptyline may enhance the response to alcohol.
+ 5-htp
highAmitriptyline slows the clearing of serotonin from nerve endings, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and raise the risk of serotonin syndrome. The amitriptyline label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic products that raise this risk; it does not name 5-HTP itself. No study or case report of amitriptyline plus 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with a different antidepressant, sertraline.
+ st. john's wort
highSt. John's wort induces the cytochrome P450 enzymes (and the P-glycoprotein transporter) that clear amitriptyline, measurably lowering amitriptyline blood levels and reducing its antidepressant and pain-relieving effect. Because both also raise serotonin signaling, combining them adds a theoretical risk of serotonin syndrome. The net effect can be a weaker antidepressant plus an added safety concern.
+ tryptophan
highAmitriptyline is a tricyclic antidepressant that slows the clearing of serotonin from nerve endings, and L-tryptophan is the amino acid the body turns into serotonin. The amitriptyline label lists tryptophan among the serotonergic products that raise the risk of serotonin syndrome, a potentially life-threatening reaction, particularly when treatment starts or the dose goes up. The warning rests on the label and the shared mechanism: no published case of serotonin syndrome from this exact pair was found, and the few older human studies that gave the two together were small and did not measure safety.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take St. John's wort with amitriptyline?⌄
Not without your prescriber. In a study of 12 patients, St. John's wort lowered amitriptyline levels by 22% and its active metabolite by 41%, and the label lists it among products that raise the risk of serotonin syndrome. If you already take both, ask before stopping either.
Is it safe to drink alcohol on amitriptyline?⌄
The label says amitriptyline may enhance the response to alcohol, adding to drowsiness and poor coordination, and this makes overdose more dangerous. Avoid alcohol unless your prescriber says otherwise.
Can I drink coffee on amitriptyline?⌄
Amitriptyline is not known to slow caffeine breakdown the way fluvoxamine does. The main question is how caffeine affects your sleep and heart rate. Ask your prescriber or pharmacist what amount is reasonable for you.
Can I take saffron, 5-HTP or tryptophan supplements with amitriptyline?⌄
Check with your pharmacist first. The label lists tryptophan among products that can cause serotonin syndrome with amitriptyline. Saffron's interaction risk is rated low and no harm has been documented, but it may act on serotonin, so tell your prescriber if you use it.
Why does amitriptyline make me so drowsy and dry-mouthed?⌄
The label describes amitriptyline as sedating, with atropine-like (anticholinergic) effects such as dry mouth, constipation and blurred vision, and older adults are especially sensitive to them. The label suggests adding dose increases at bedtime and allows the whole maintenance dose then; talk to your prescriber if side effects bother you.
References by claim
depression in adults
Cipriani et al., 2018 · PMC (2018) link
nerve (neuropathic) pain, an off-label use
Moore et al., 2015 · PMC (2015) link
Safety
Amitriptyline hydrochloride tablets prescribing information · DailyMed (FDA label) link
Interaction: St. John's wort
Johne et al., 2002 · PubMed (2002) link
Interaction: Saffron extract
Lopresti et al., 2014 · PubMed (2014) link
Interaction: 5-HTP (5-hydroxytryptophan)
Patel et al., 2017 · PMC (2017) link
Track Amitriptyline with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
